Aizpea Barona-Echebarria

Barakaldo, PV 48940, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 11, 2025

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol.

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol.

Journal: Pharmaceutics
Published: October 07, 2024

Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas.

Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas.

Journal: Translational pediatrics
Published: February 02, 2023

Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.

Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.

Journal: Scientific reports
Published: November 10, 2022

Appearances are deceiving: immature lymphocytes in Leishmaniasis.

Appearances are deceiving: immature lymphocytes in Leishmaniasis.

Journal: Blood research
Published: October 19, 2021

Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas.

Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas.

Journal: Cancers
Published: September 08, 2021

Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital.

Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital.

Journal: Anales de pediatria
Published: June 16, 2021

Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.

Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.

Journal: The pharmacogenomics journal
Published: April 23, 2017

Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.

Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.

Journal: The pharmacogenomics journal
Published: January 24, 2017

Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.

Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.

Journal: Pharmacogenomics
Published: May 17, 2016

Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.

Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.

Journal: Pharmacogenetics and genomics
Published: December 01, 2015

The current situation of adolescents with cancer in pediatric hematology-oncology units in Spain. Results of a national survey

The current situation of adolescents with cancer in pediatric hematology-oncology units in Spain. Results of a national survey

Journal: Anales de pediatria (Barcelona, Spain : 2003)
Published: September 07, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026